ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $37,756,000 | +33.2% | 2,766,008 | 0.0% | 0.95% | +4.5% |
| Q4 2018 | $28,352,000 | -24.9% | 2,766,008 | +22.1% | 0.91% | -9.0% |
| Q3 2018 | $37,729,000 | +5.4% | 2,266,008 | 0.0% | 1.00% | -3.5% |
| Q2 2018 | $35,803,000 | +24.4% | 2,266,008 | 0.0% | 1.03% | +30.1% |
| Q1 2018 | $28,778,000 | +10.9% | 2,266,008 | 0.0% | 0.80% | +8.8% |
| Q4 2017 | $25,946,000 | -6.5% | 2,266,008 | 0.0% | 0.73% | -4.8% |
| Q3 2017 | $27,759,000 | +24.9% | 2,266,008 | +16.7% | 0.77% | +13.1% |
| Q2 2017 | $22,225,000 | -36.6% | 1,941,008 | +15.2% | 0.68% | -40.8% |
| Q1 2017 | $35,051,000 | 0.0% | 1,685,150 | 0.0% | 1.15% | -11.6% |
| Q4 2016 | $35,051,000 | -36.5% | 1,685,150 | 0.0% | 1.30% | -33.1% |
| Q3 2016 | $55,222,000 | +31.2% | 1,685,150 | 0.0% | 1.94% | +16.9% |
| Q2 2016 | $42,078,000 | +13.8% | 1,685,150 | +11.6% | 1.66% | +13.0% |
| Q1 2016 | $36,984,000 | -25.9% | 1,510,150 | 0.0% | 1.47% | +4.6% |
| Q4 2015 | $49,880,000 | +0.8% | 1,510,150 | 0.0% | 1.40% | -10.5% |
| Q3 2015 | $49,473,000 | -19.1% | 1,510,150 | +30.7% | 1.57% | -5.4% |
| Q2 2015 | $61,188,000 | – | 1,155,150 | – | 1.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|